Kevin Healey
Directeur/Membre du Conseil chez YM BioSciences Australia Pty Ltd.
Profil
Kevin Healey is the founder of Cytopia Ltd.
which was founded in 1997.
He was a Non-Executive Director at Cytopia Ltd.
from 2010 to 2011.
Currently, he is a Director at YM BioSciences Australia Pty Ltd.
and a Manager-Business Development at Vision Systems Pty Ltd.
He previously worked as the Chief Executive Officer, Director & MD at Hunter Immunology Pty Ltd.
and as a Director at Xenome Ltd.
He was also a Non-Executive Director at The Sustainable Nutrition Group Pty Ltd.
in 2006.
Postes actifs de Kevin Healey
| Sociétés | Poste | Début |
|---|---|---|
Vision Systems Pty Ltd.
 Vision Systems Pty Ltd. Medical SpecialtiesHealth Technology Vision Systems Pty Ltd. develops, manufactures, and distributes technology products and services to the healthcare markets. It produces automated system solutions and vitro diagnostic instruments for cancer detection. The company was founded in 1984 and is headquartered in Mount Waverley, Australia. | Corporate Officer/Principal | 02/03/2010 |
YM BioSciences Australia Pty Ltd.
 YM BioSciences Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., YM BioSciences Australia Pty Ltd. develops cancer treatment pharmaceuticals. The company is based in Melbourne, Australia. | Directeur/Membre du Conseil | 02/03/2010 |
Anciens postes connus de Kevin Healey
| Sociétés | Poste | Fin |
|---|---|---|
Cytopia Ltd.
 Cytopia Ltd. Pharmaceuticals: MajorHealth Technology Cytopia Ltd. primarily engages in discovers and develops drugs to treat cancer and other diseases. The company commenced operations in 1997 in Melbourne, Australia, and has developed kinase enzyme biology and integrated a robust structural biology program with medicinal chemistry & drug development. The company conducts its research and drug development through subsidiaries based in Australia and the USA and also develops small molecule compounds with therapeutic profile for the treatment of cancer. The company has concluded two phase I safety and tolerability studies for its lead anticancer vascular disrupting agent, CYT997. It was founded on August 11, 1997 and is located in Melbourne, VI. | Fondateur | 01/06/2011 |
Hunter Immunology Pty Ltd.
 Hunter Immunology Pty Ltd. Medical SpecialtiesHealth Technology Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia. | President | 07/04/2011 |
| THE SUSTAINABLE NUTRITION GROUP LTD | Directeur/Membre du Conseil | 18/09/2006 |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cytopia Ltd.
Cytopia Ltd. Pharmaceuticals: MajorHealth Technology Cytopia Ltd. primarily engages in discovers and develops drugs to treat cancer and other diseases. The company commenced operations in 1997 in Melbourne, Australia, and has developed kinase enzyme biology and integrated a robust structural biology program with medicinal chemistry & drug development. The company conducts its research and drug development through subsidiaries based in Australia and the USA and also develops small molecule compounds with therapeutic profile for the treatment of cancer. The company has concluded two phase I safety and tolerability studies for its lead anticancer vascular disrupting agent, CYT997. It was founded on August 11, 1997 and is located in Melbourne, VI. | Health Technology |
Vision Systems Pty Ltd.
Vision Systems Pty Ltd. Medical SpecialtiesHealth Technology Vision Systems Pty Ltd. develops, manufactures, and distributes technology products and services to the healthcare markets. It produces automated system solutions and vitro diagnostic instruments for cancer detection. The company was founded in 1984 and is headquartered in Mount Waverley, Australia. | Health Technology |
YM BioSciences Australia Pty Ltd.
YM BioSciences Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., YM BioSciences Australia Pty Ltd. develops cancer treatment pharmaceuticals. The company is based in Melbourne, Australia. | Health Technology |
Hunter Immunology Pty Ltd.
Hunter Immunology Pty Ltd. Medical SpecialtiesHealth Technology Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia. | Health Technology |
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
The Sustainable Nutrition Group Pty Ltd.
 The Sustainable Nutrition Group Pty Ltd. Agricultural Commodities/MillingProcess Industries The Sustainable Nutrition Group Ltd. produces, manufactures, and distributes a range of hemp products in Australia. It is involved in hemp seed selection, farming, processing, and packaging, as well as distribution and sale of bulk and retail products. The company's products include hand sanitizers, hemp oils, hemp seeds, hemp protein powders, and hemp flour under the APH and Mt Elephant brands to retail, wholesale, and white label customers. The company was founded by James Hood and Tracie Rams dale in 1995 and is headquartered in Newtown, Australia. | Process Industries |